Patient health information platform Healthvana has partnered with Los Angeles County to provide COVID-19 vaccination tracking to recipients. Primarily, the system will send patients followup reminders to return for the required second dose of the Pfizer-BioNTech or Moderna vaccines.
But Healthvana also says its records create a verifiable proof of vaccination. That proof, sometimes discussed as a “vaccine passport,” could allow safer protocols for public gatherings or other settings where transmission risk is high as the vaccine becomes more widely available.
In Los Angeles, where the spread of the novel coronavirus has reached crisis levels, the Healthvana records will supplement paper reminder cards given to recipients of a first vaccine dose. Though vaccine records are also kept by medical facilities, County officials tell Bloomberg that medical administrators don’t have the capacity to track the timing of millions of necessary followup doses and inform patients directly.
That matters because the two COVID-19 vaccines currently approved for emergency use in the U.S. are only fully effective after a second dose. Studies based on other multi-dose vaccines show that a large proportion of patients, particularly the elderly, disabled, and members of minority groups, do not return for a second dose. That could slow the progress to the vaccination threshold of roughly 80% that health authorities say is needed to control the pandemic in the U.S.
The Healthvana system also creates proof of a completed vaccination sequence that can be stored digitally in an Apple Wallet or similar systems. Those systems already provide authenticated and secure storage of official records such as student IDs, airline boarding passes, and event tickets.
Secure digital vaccine records could in theory be used to safely allow access to places or activities, such as airlines or public events, where there is a high risk of coronavirus transmission. Healthvana says it is in discussions with such facilities about using its certifications for that purpose. However, there is currently no official state or national U.S. policy—or broad private-sector consensus—about how such a system might work.
More must-read tech coverage from Fortune:
- Intuit’s CEO on the $7.1 billion Credit Karma acquisition, reorienting toward A.I., and reskilling workers
- Commentary: The broken business model of Uber and Lyft is taking a heavy toll on society
- WarnerMedia Studios chief on the controversial decision to release new movies on HBO Max
- Look out for these new smartphone features in 2021
- LinkedIn saw a massive influx in user posts and violations this year
The maker behind the world’s first-ever PMS gummy vitamin
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.
U.S. and EU agree to suspend tariffs amid hopes of a ‘fresh start’ from the bruising Trump trade wars
The truce means a pause on tariffs levied against aircraft, wine, food and other products, many of which stem from the Trump era trade war.
Brexit has saddled its champions with an impossible dilemma
The Northern Ireland problem keeps getting more problematic. Read More